HemaSphere
(Jun 2022)
P1485: A MULTICENTER, RETROSPECTIVE STUDY ON REAL-WORLD EXPERIENCE OF PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR
- B. Andemariam,
- M. Idowu,
- N. Shah,
- R. Drachtman,
- A. Sharma,
- A. Glaros,
- M. Achebe,
- A. Nero,
- S. Curtis,
- C. Minnitti
Affiliations
- B. Andemariam
- 1 New England Sickle Cell Institute, University of Connecticut Health, Farmington
- M. Idowu
- 2 University of Texas Health, Houston
- N. Shah
- 3 Duke University School of Medicine, Durham
- R. Drachtman
- 4 Rutgers Robert Wood Johnson Medical School, New Brunswick
- A. Sharma
- 4 Rutgers Robert Wood Johnson Medical School, New Brunswick
- A. Glaros
- 5 Division of Pediatric Hematology/Oncology, Central Michigan University, Detroit
- M. Achebe
- 6 Brigham and Women’s Hospital, Boston
- A. Nero
- 7 University of Texas Southwestern Medical Center, Dallas
- S. Curtis
- 8 Albert Einstein College of Medicine, Bronx, United States of America
- C. Minnitti
- 8 Albert Einstein College of Medicine, Bronx, United States of America
- DOI
-
https://doi.org/10.1097/01.HS9.0000848796.59624.5a
- Journal volume & issue
-
Vol. 6
pp.
1367
– 1368
WeChat QR code